WARNINGS for Investors - Before investing funds in shares of a company that is a startup with patented and implemented technology, it is recommended that the investor familiarize themselves with the risks associated with investing in commercial law companies outlined below. Every investment decision by the investor should be made considering the following risks. Oraquel SA, based in Poland, assumes no liability towards the investor in the event that the risks outlined below materialize concerning the shares of Oraquel SA based in Poland, the information about which is published on the Oraquel.com website. The indicated risks are not exhaustive. For a comprehensive analysis of the risks associated with investing in shares of companies in the Pre IPO stage, it is recommended that the investor contact a professional advisor, including legal and financial advisors.

• Risk of low dividend frequency or lack of dividends - Companies raising capital in the Pre IPO stage do not guarantee periodic dividend payments. A dividend is not a payment that is owed to a shareholder of a joint-stock company by law. The payment of dividends requires the company to demonstrate profit for the given financial year and for the general meeting to adopt a resolution on profit distribution and dividend payment. A significant portion of companies raising funds from investors are in the development phase, and any profits generated by the companies from their business activities will subsequently be reinvested, meaning that these funds will not be allocated for dividend payments to shareholders. The payment of dividends to shareholders is possible; however, it is not guaranteed by the companies raising funds in the Pre IPO stage.

• Risk of limited ability to sell shares - An investor acquiring shares of a company in the Pre IPO stage subsequently has the option to sell those shares, e.g., based on a civil law sales agreement. However, it is the investor's responsibility to find a buyer for the shares. Companies raising capital do not guarantee assistance to the investor in finding such a buyer. Currently, there is no secondary market for shares of companies raising funds in the Pre IPO stage, where automated transactions can be made through placing buy and sell orders. The liquidity of shares may increase if the issuance of shares on the public market (GPW or NewConnect) begins, although entry into this market is not guaranteed by the companies raising funds in the Pre IPO stage. Additional restrictions on the sale of shares may also arise from documents such as the company's articles of association, e.g., the need to obtain the approval of the general meeting of the joint-stock company for the sale of registered shares. Before making an investment, the investor should therefore familiarize themselves with the content of the agreement/articles of association of the company.

• Risk of capital loss - Companies raising funds in the Pre IPO stage do not guarantee the investor a return on their investment. A large portion of the companies are startups, and some of them may be considered high-risk companies. This may be related, for example, to the development of an innovative product by the company, for which there is no guarantee of market demand. Consequently, there is a risk of the company's operations failing, which could lead to its bankruptcy or liquidation, and for the investor, this could mean a definitive lack of possibility to recover the invested capital. Investing in shares of companies is not debt financing, which means that the investor cannot expect a return of the invested capital from the company on similar terms as in the case of a loan agreement. The decision to invest in a company's shares should be made with consideration of the principle of diversification, i.e., investing capital in various assets with different levels of liquidity and risk.

• Risk of dilution of equity in the company's share capital - Companies raising funds in the Pre IPO stage often conduct several rounds of investment, among other things, to continuously acquire funds for their own operations. Conducting a financing round usually involves increasing the company's share capital and issuing new shares for additional investors. Existing shareholders of the company have the preemptive right to new shares issued in the capital increase. However, this right may be excluded based on a resolution of the general meeting. This means that the percentage share in the company's share capital held by an investor who invested funds in the company's shares during the first rounds of financing will be diluted as a result of further financing rounds and the entry of new investors into the company. The dilution of the share will have an impact on reducing the share of the overall voting rights and the amount of any potential dividend.

• Risk associated with the lack of significant influence of the investor on the company's operations - Investors in the Pre IPO stage typically hold a small percentage of the total number of shares in the company's share capital. Each investor possesses a certain package of rights associated with share ownership, e.g., the right to participate in the general meeting and the right to vote at the general meeting. However, the status of a minority shareholder does not entitle them to independently vote on resolutions at the general meeting or to appoint members of the management board or supervisory board. A minority shareholder does not have direct influence over the company's current operations, which is the domain of the company's management. The scope of rights of a minority shareholder may also be affected by any rights assigned to other shareholders, including majority shareholders, e.g., preferred shares or personal rights to appoint and dismiss members of the management board or supervisory board. It is recommended that the investor familiarize themselves with the company's agreement/statute in order to verify the exact scope of rights they will have in the company, as well as the scope of rights of other shareholders.

• Risk associated with the valuation of the company - The valuation of the company, which serves as the basis for determining the issue price of shares acquired by investors, does not always reflect the actual value of the company. This valuation is determined by the company itself, and legal regulations do not require this valuation to be verified by an auditor or another professional entity. This valuation is often made by considering elements such as the company's projected revenues, growth prospects, etc. However, these valuations take less into account the value of the assets (property) that the company possesses at that moment. From the investor's perspective, this can be significant in the event of a later sale of the shares, as the investor may not receive the same price from the buyer as the price they paid for the shares of that company.

The valuation of the company as of December 31, 2025, is 16,000,000.00 Euros

The valuation is based on partnership agreements, letters of intent, intellectual property, contracts, and forecasts. (issuers - emitting over 60,000,000 tons of CO2 annually).

Pre-IPO is for us "an entry into the back office of the stock exchange"

We invite you to contact us and register for shares of Oraquel SA.

write to us at: invest@oraquel.com or fill out the contact form by clicking the button

The Hi-DAC Reactor Oraquel created by us is based on patented hybrid sorbent filter technology, which is an invention of Oraquel. One Hi-DAC Reactor Oraquel can capture up to 500 tons of carbon dioxide per year. The storage of captured carbon dioxide is done in one of the safest and cheapest ways possible, namely underground at depths ranging from 30 to 300 meters below the earth's surface in old shafts and mines, in accordance with the applicable laws of individual European Union countries.

We collaborate with many CO2 emitters in Poland and Europe. Local governments, ministries, large companies (emitters).

Currently, we are implementing several pilot installations, thanks to which the technology we have introduced will begin to work for the environment around us.

We know how to respond to the needs of our current partners and how to reach new potential clients and recipients.

Oraquel SA calls on those interested in investing in Pre-IPO shares (Initial Public Offering) Oraquel SA to subscribe for shares of the Company issued in a private subscription (series B shares issued by the company, new issuance). This Pre-IPO allows for early access to company shares, a lower share price, and the potential for higher profits. The company will generate revenue from the sale of the technology itself (patented invention), the sale of devices (Hi-DAC reactor), and the sale of green certificates compatible with the European ETS system. The total value of the CO2 certificate market exceeds 1 trillion euros.

The disadvantages and risks of Pre-IPO include lower liquidity (more difficult to sell shares outside the stock exchange), limited information about the company (startup with patented and implemented technology), and higher risk.

The company is currently undertaking several pilot projects, and with the increasing number of installed reactors (also as part of the pilot program), the value of the company's shares will steadily rise.

We have combined modern technology, years of experience from outstanding specialists in Europe and Switzerland, along with the work of advanced laboratories and institutes.

We want to develop the entire European market and then direct our efforts globally. To accelerate the achievement of these goals, we have decided to issue shares of Oraquel joint-stock company.

The construction of the NULL WALD center - the largest facility in Europe that absorbs carbon dioxide from the atmosphere.

By investing in Oraquel SA, you are investing in the CO2 emission market in Europe, worth nearly1 trillion euros (1,000,000,000,000 - trillion).. You gain the opportunity to multiply your capital while also contributing your part to preventing climate change.

What are our next goals?

Oraquel SA is a technological company focused on combating climate change, revolutionizing the capture of carbon dioxide directly from the air (direct air capture) and encouraging everyone to support climate change prevention processes.

Carbon dioxide emissions in Poland are currently among the highest in the world. The technology implemented by Oraquel SA, at the appropriate scale, can significantly reduce historical emissions.

The company holds the necessary trademarks and patents while simultaneously working on additional inventions that will provide further intellectual value to Oraquel SA.

We have tamed the chaos that has always accompanied CO2 emissions!

Visit us:

© 2026 Oraquel.